Triazavirin—A Novel Effective Antiviral Drug

This review outlines the data of numerous studies relating to the broad-spectrum antiviral drug Triazavirin that was launched on the Russian pharmaceutical market in 2014 as an anti-influenza drug (the international non-patented name is Riamilovir). The range of antiviral activity of Triazavirin has...

Descripción completa

Detalles Bibliográficos
Autores principales: Chupakhin, Oleg N., Rusinov, Vladimir L., Varaksin, Mikhail V., Ulomskiy, Evgeny N., Savateev, Konstantin V., Butorin, Ilya I., Du, Weijie, Sun, Zhiyong, Charushin, Valery N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738222/
https://www.ncbi.nlm.nih.gov/pubmed/36498864
http://dx.doi.org/10.3390/ijms232314537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738222/
https://www.ncbi.nlm.nih.gov/pubmed/36498864
http://dx.doi.org/10.3390/ijms232314537

Ejemplares similares